- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00212485
Study to Evaluate the Use of Ultrasound in the Diagnosis of Hemophilic Joint Disease
Evaluation of the Role of Power Doppler Sonography in the Diagnosis of Hemophilic Joint Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim #1 - To determine if PDS can be used to diagnose synovial hypertrophy and inflammation in joint disease associated with inherited bleeding disorders. MRI will be used as a reference standard.
Aim #2 - To determine if PDS can be used to assess therapeutic response to treatment.
Aim #3 - To determine if PDS can be used as a screening tool for diagnosing early synovitis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- New York Presbyterian Hospital/Hospital for Special Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of inherited bleeding disorder
For Aim 1:
- Age of at least 6 years
- History of at least 4 bleeds in the same joint in the preceding 6 months
- Joint swelling, synovitis or deformity
For Aim 2:
- Meet inclusion criteria for Aim 1 and will be having a synovectomy
For Aim 3:
- Age of at least 1 year
- Have had at least 2 joint bleeds
Exclusion Criteria:
- Not meeting inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of magnetic resonance imaging (MRI) and power Doppler sonograms on patients with target joint
Time Frame: Up to 1 month
|
Up to 1 month
|
|
Evaluation of PDS on patients with target joints pre and post synovectomy to assess response to therapeutic intervention
Time Frame: 1. day of synovectomy; 2. 6 months post synovectomy.
|
1. day of synovectomy; 2. 6 months post synovectomy.
|
|
Evaluation of PDS on patients with at least 2 joint bleeds to diagnose early synovitis
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Suchitra S Acharya, MD, Weill Medical College of Cornell University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PDS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inherited Bleeding Disorders
-
Sohag UniversityRecruitingRare Inherited Bleeding Disorders in Children at Sohag University HospitalEgypt
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseGermany
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Acquired HaemophiliaFrance
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AIndia
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Germany, Switzerland, Macedonia, The Former Yugoslav Republic of, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Israel, Russian Federation, Turkey, Lithuania, Poland, Japan, Latvia, Puerto...
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Australia, France, Canada, Malaysia, Mexico, Austria, Serbia, Japan, Germany, Greece, Algeria, Italy, Romania, Portugal, Israel, Bulgaria, Ukraine, Taiwan, Argentina, Thailand, Puerto Rico
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, Japan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Puerto Rico, Norway, Korea, Republic of, Bulgaria, Russian...
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AChina
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Germany, Switzerland, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Japan, Denmark, Hungary, Israel, Turkey, Russian Federation, Former Serbia and Montenegro
-
BayerRecruitingHemophilia A | Prophylaxis of Bleeding | Treatment of BleedingSouth Korea
Clinical Trials on Power Doppler Sonography
-
University Hospital Inselspital, BerneCompletedCerebral PerfusionSwitzerland
-
John Paul II Hospital, KrakowRecruitingHeart Failure | Cognitive Impairment | Carotid StenosisPoland
-
Centre Hospitalier St AnneFondation de l'Avenir; Fondation pour les Sciences du Cerveau; Association NEUROREFSTerminatedPartial Drug-resistant EpilepsyFrance
-
Radboud University Medical CenterUnknownPulmonary Hypertension of the Newborn (PPHN)Netherlands
-
Peking University Third HospitalRecruiting
-
University Hospital, MontpellierCentral Hospital, Nancy, France; Centre Hospitalier de la côte Basque; University... and other collaboratorsCompletedObsessional ErotomaniaFrance
-
Swiss Paraplegic Research, NottwilLotte und Adolf Hotz-Sprenger StiftungCompletedRenal Insufficiency | Spinal Cord InjuriesSwitzerland
-
Ain Shams Maternity HospitalCompleted
-
University Hospitals of Derby and Burton NHS Foundation...Not yet recruitingRecurrent Miscarriage